742
Views
14
CrossRef citations to date
0
Altmetric
Review Article

Controversies in Juvenile Idiopathic Arthritis-associated Uveitis

, MD, PhD, , MD, PhD, , MD, PhD, , Jr MD, PhD & , MD, PhD
Pages 167-179 | Received 19 Apr 2013, Accepted 25 Apr 2013, Published online: 29 May 2013

References

  • Edelsten C, Lee V, Bentley CR, et al. An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood. Br J Ophthalmol. 2002;86:51–56
  • Kotaniemi K, Savolainen A, Karma A, Aho K. Recent advances in uveitis of juvenile idiopathic arthritis. Surv Ophthalmol. 2003;48:489–502
  • Gregory AC 2nd, Kempen JH, Daniel E, et al; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Research Group. Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: The Systemic Immunosuppressive Therapy for Eye Diseases Study. Ophthalmology. 2013;120(1):186–192
  • Carvounis PE, Herman DC, Cha S, et al. Incidence and outcomes of uveitis in juvenile rheumatoid arthritis, a synthesis of the literature. Graefés Arch Clin Exp Ophthalmol. 2006;244:281–290
  • Säilä H, Kotaniemi K, Savolainen A, et al. Uveitis in sibling pairs with juvenile idiopathic arthritis. Rheumatology. 2001;40:221–224
  • Qian Y, Acharya NR. Juvenile idiopathic arthritis-associated uveitis. Curr Opin Ophthalmol. 2010;21:468–472
  • Pratsidou-Gertsi P, Kanakoudi-Tsakalidou F, Spyropoulou M, et al. Nationwide collaborative study of HLA class II associations with distinct types of juvenile chronic arthritis (JCA) in Greece. Eur J Immunogenet. 1999;26:299–310
  • Heiligenhaus A, Niewerth M, Ganser G, et al. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology. 2007;46:1015–1019
  • Saurenmann RK, Rose JB, Tyrrell P, et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort. Ethnicity as a risk factor. Arthritis Rheum. 2007;56:1974–1984
  • Keenan JD, Tessler HH, Goldstein DA. Granulomatous inflammation in juvenile idiopathic arthritis-associated uveitis. J AAPOS. 2008;12:546–50
  • Kotaniemi K, Arkela-Kautiainen M, Haapasaari J, et al. Uveitis in young adults with juvenile idiopathic arthritis: a clinical evaluation of 123 patients. Ann Rheum Dis. 2005;64:871–874
  • Chan CC, Ree F, Kim Y, et al. A correlation of pregnancy term, disease activity, serum female hormones, and cytokines in uveitis. Br J Ophthalmol. 2004;88:1506–1509
  • Davis JL, Dacanay LM, Holland GN, et al. Laser flare photometry and complications of chronic uveitis in children. Am J Ophthalmol. 2003;135:763–771
  • Tappeiner C, Heinz C, Roesel M, Heiligenhaus A. Elevated laser flare values correlate with complicated course of anterior uveitis in patients with juvenile idiopathic arthritis. Acta Ophthalmol. 2011;89:521–527
  • Ducos de Lahitte G, Terrada C, Tran TH, et al. Maculopathy in uveitis of juvenile idiopathic arthritis: an optical coherence tomography study. Br J Ophthalmol. 2008;92:64–69
  • Petty R, Smith JR, Rosenbaum JT. Arthritis and uveitis in children: pediatric rheumatology perspective. Am J Ophthalmol. 2003;135:879–884
  • Wakefield D, Zierhut M. Controversies in intraocular lymphoma. Ocul Immunol Inflamm. 2009;17:4–5
  • Wakefield D, Zierhut M. Controversy: ocular sarcoidosis. Ocul Immunol Inflamm. 2010;18:5–9
  • Wakefield D, Cunningham ET Jr, Pavesio C, et al. Controversies in ocular toxoplasmosis. Ocul Immunol Inflamm. 2011;19:2–9
  • Wakefield D, Cunningham ET Jr, Tugal-Tutkun I, et al. Controversies in Behçet disease. Ocul Immunol Inflamm. 2012;20:6–11
  • Biester S, Deuter C, Michels H, et al. Adalimumab in the therapy of uveitis in childhood. Br J Ophthalmol. 2007;319–324
  • Sijssens KM, Los LI, Rothova A, et al. Long-term ocular complications in aphakic versus pseudophakic eyes of children with juvenile idiopathic arthritis-associated uveitis. Br J Ophthalmol. 2010;94:1145–1149

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.